
### [DOID:305](http://purl.obolibrary.org/obo/DOID_305)
**Label:** carcinoma

**Subclasses:** [DOID:4450](http://purl.obolibrary.org/obo/DOID_4450) (renal cell carcinoma), [DOID:8161](http://purl.obolibrary.org/obo/DOID_8161) (thyroid Hurthle cell carcinoma), [DOID:4279](http://purl.obolibrary.org/obo/DOID_4279) (infundibulocystic basal cell carcinoma), [DOID:0050547](http://purl.obolibrary.org/obo/DOID_0050547) (familial medullary thyroid carcinoma), [DOID:3962](http://purl.obolibrary.org/obo/DOID_3962) (follicular thyroid carcinoma), [DOID:5520](http://purl.obolibrary.org/obo/DOID_5520) (head and neck squamous cell carcinoma), [DOID:6126](http://purl.obolibrary.org/obo/DOID_6126) (anal canal carcinoma), [DOID:1540](http://purl.obolibrary.org/obo/DOID_1540) (parathyroid carcinoma), [DOID:4465](http://purl.obolibrary.org/obo/DOID_4465) (papillary renal cell carcinoma), [DOID:5409](http://purl.obolibrary.org/obo/DOID_5409) (lung small cell carcinoma), [DOID:0050387](http://purl.obolibrary.org/obo/DOID_0050387) (nonpapillary renal cell carcinoma), [DOID:684](http://purl.obolibrary.org/obo/DOID_684) (hepatocellular carcinoma), [DOID:3969](http://purl.obolibrary.org/obo/DOID_3969) (papillary thyroid carcinoma), [DOID:2513](http://purl.obolibrary.org/obo/DOID_2513) (basal cell carcinoma), [DOID:4905](http://purl.obolibrary.org/obo/DOID_4905) (pancreatic carcinoma), 

**Corr. equiv. classes:** [OMIM:105580](http://purl.obolibrary.org/obo/OMIM_105580), [OMIM:155240](http://purl.obolibrary.org/obo/OMIM_155240), [OMIM:260350](http://purl.obolibrary.org/obo/OMIM_260350), [OMIM:188550](http://purl.obolibrary.org/obo/OMIM_188550), [OMIM:613061](http://purl.obolibrary.org/obo/OMIM_613061), [OMIM:188470](http://purl.obolibrary.org/obo/OMIM_188470), [OMIM:613063](http://purl.obolibrary.org/obo/OMIM_613063), [OMIM:182280](http://purl.obolibrary.org/obo/OMIM_182280), [OMIM:613062](http://purl.obolibrary.org/obo/OMIM_613062), [OMIM:114550](http://purl.obolibrary.org/obo/OMIM_114550), [OMIM:300854](http://purl.obolibrary.org/obo/OMIM_300854), [OMIM:613058](http://purl.obolibrary.org/obo/OMIM_613058), [OMIM:613059](http://purl.obolibrary.org/obo/OMIM_613059), [OMIM:275355](http://purl.obolibrary.org/obo/OMIM_275355), [OMIM:607464](http://purl.obolibrary.org/obo/OMIM_607464), [OMIM:605462](http://purl.obolibrary.org/obo/OMIM_605462), [OMIM:608266](http://purl.obolibrary.org/obo/OMIM_608266), [OMIM:144700](http://purl.obolibrary.org/obo/OMIM_144700), [OMIM:604451](http://purl.obolibrary.org/obo/OMIM_604451), [OMIM:605074](http://purl.obolibrary.org/obo/OMIM_605074), 

**Class expressions from DL-Learner:**

- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 40.06%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 40.06%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 40.06%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 39.38%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 36.40%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 35.50%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 31.67%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 31.13%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 29.83%
- Thing 29.79%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 29.79%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 25.35%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 25.30%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 21.69%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) 21.66%


